NCT03732651

Brief Summary

The investigators hypothezised that CO2-reactivity of cerebral vessels is affected by systemic non-pulsatile blood flow. Patients undergoing elective cardiac surgery with CPB were enrolled in this prospective case control study. Blood flow velocity in the middle cerebral artery as well as regional cerebral oxygenation was determined during step changes of PaCO2 between 30, 40, and 50 mmHg. Measurements were conducted intraoperatively during non-pulsatile as well as postoperatively after admission to the ICU under pulsatile blood flow.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2008

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 11, 2008

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 11, 2012

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2013

Completed
4.9 years until next milestone

First Submitted

Initial submission to the registry

October 30, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

November 6, 2018

Completed
Last Updated

November 6, 2018

Status Verified

November 1, 2018

Enrollment Period

4.3 years

First QC Date

October 30, 2018

Last Update Submit

November 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • CO2- Reactivity of cerebral vessels during cardiopulmonary bypass using nonpulsatile blood flow and postoperative on ICU under physiological pulsatile blood flow

    Relation between PaCO2 level and cerebral blood flow velocity will be assessed during non-pulsatile and pulsatile blood flow. Measurements will be performed using trancranial doppler to measure flow velocity of the middle cerebral artery. Further, NIRS will be used to measure oxygen saturation of the brain. Measurements will be performed during step changes of PaCO2 (at 30mmHg, 40mmHg and 50mmHg.

    first time-point: intraoperative, during cardiopulmonary bypass, duration up to 300minutes. Second time-point: on ICU, postoperatively under pulsatile blood flow, duration of measurement up to 100minutes for each patient

Study Arms (2)

non-pulsatile blood flow

EXPERIMENTAL
Procedure: alteration of PaCO2 level

pulsatile blood flow

EXPERIMENTAL
Procedure: alteration of PaCO2 level

Interventions

step changes between 30, 40 and 50 mmHg

non-pulsatile blood flowpulsatile blood flow

Eligibility Criteria

Age15 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • undergoing elective cardiac surgery with cardiopulmonary bypass

You may not qualify if:

  • Carotid artery stenosis (\> 50%)
  • Neurological pathologies
  • COPD with CO2 retention
  • Women of childbearing age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

medical University of Vienna

Vienna, 1090, Austria

Location

Related Publications (1)

  • Veraar CM, Rinosl H, Kuhn K, Skhirtladze-Dworschak K, Felli A, Mouhieddine M, Menger J, Pataraia E, Ankersmit HJ, Dworschak M. Non-pulsatile blood flow is associated with enhanced cerebrovascular carbon dioxide reactivity and an attenuated relationship between cerebral blood flow and regional brain oxygenation. Crit Care. 2019 Dec 30;23(1):426. doi: 10.1186/s13054-019-2671-7.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Each patient served as his own control.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cecilia Veraar

Study Record Dates

First Submitted

October 30, 2018

First Posted

November 6, 2018

Study Start

June 11, 2008

Primary Completion

October 11, 2012

Study Completion

December 2, 2013

Last Updated

November 6, 2018

Record last verified: 2018-11

Locations